EN
HI
Summary
As of 2 Sep, 2026, Emcure Pharmaceuticals stock price is ₹1845.9. During the trading session, the stock has moved between an intraday low of ₹1835.00 and an intraday high of ₹1885.00. Over the last 52 weeks, Emcure Pharmaceuticals has traded between ₹1260.00 and ₹2048.00.
The stock has recorded a trading volume of 1,14,806 shares, with a market capitalization of ₹189659547. Its Average Traded Price (ATP) is ₹1851.81, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹1845.90.
Emcure Pharmaceuticals has an upper circuit limit of ₹2040.80 and a lower circuit limit of ₹1669.80. The total value traded stands at ₹21.26 CR, and the delivery percentage for the day is 43.75%.
The stock is currently traded with a market lot size of 1. Emcure Pharmaceuticals also offers a dividend yield of 0.19%.
Emcure Pharmaceuticals share price chart
Emcure Pharmaceuticals Share Key Metrics
Volume
1.15 L
Market Cap
35009.26 CR
LTQ@LTP
3@1845.90
ATP
1851.81
Var Margin
16.43 %
Circuit Range
1669.8-2040.8
Delivery %
43.75 %
Value
21.26 CR
ASM/GSM
No
Market Lot
1
Emcure Pharmaceuticals Fundamentals
P/E Ratio
34.82
P/B Ratio
6.73
Div. Yield
0.19
Sector P/E
41.23
Sector P/B
3.52
Sec. Div. Yield
0.51
Emcure Pharmaceuticals Resistance and Support
Pivot 1860.67
Resistance
First Resistance
1882.74
Second Resistance
1910.17
Third Resistance
1932.24
Support
First Support
1833.24
Second Support
1811.17
Third Support
1783.74
Emcure Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 01 2026 | 1860.9 | 1845.9 | -0.51% | 1885 | 1835 |
| Mon Aug 31 2026 | 1879 | 1855.3 | -0.75% | 1888.09 | 1838.59 |
| Fri Aug 28 2026 | 1878.9 | 1869.4 | -0.48% | 1893 | 1850 |
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals News
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Credit Rating
CARE Ratings Limited reaffirmed Emcure Pharmaceuticals' long-term bank facilities rating at CARE AA; Stable and short-term facilities at CARE A1+. This reaffirmation reflects the company's healthy business risk profile and improved operating profitability in FY26.
Sep 01 2026 15:44:17
Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Emcure Pharmaceuticals released the transcript of its Q1 FY27 earnings call, highlighting robust financial performance with revenue increasing 22.8% to Rs.2,580 crore and profit after tax growing 36.2% to Rs.292 crore. The company projects low to mid-teen revenue growth and 70-100 bps EBITDA margin expansion for FY27.
Aug 12 2026 18:35:05
Read More
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Ajanta Pharma Ltd.
3504.80
-97.10 (2.70%)
Global Health Ltd.
1458.10
-21.60 (1.46%)
Narayana Hrudayalaya Ltd.
1938.70
31.50 (1.65%)
Dr. Lal Pathlabs Ltd.
1904.40
-30.20 (1.56%)
Krishna Institute of Medical Sciences Ltd
758.40
2.90 (0.38%)
Wockhardt Ltd.
1850.60
-33.10 (1.76%)
Sai Life Sciences Ltd.
1518.10
58.40 (4.00%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 1845.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 34.82. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 6.73. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.23 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 35009.26 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 2048.00 & 1260.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
